Novo Nordisk A/S
is a global healthcare company founded in 1923 and headquartered in Denmark. The company develops treatments for diabetes and weight management, including widely popular drugs such as Ozempic, Wegovy, Rybelsus, Victoza, and Saxenda, along with a broad lineup of insulin products. Novo Nordisk employs 67,900 people in 80 countries and markets its products in around 170 countries.
